Doceree at CES 2026: Reinforcing Its Leadership in HCP Marketing

CES 2026 once again underscored how rapidly technology, data, and AI are reshaping digital ecosystems. For Doceree, the Consumer Electronics Show (January 6–9, 2026, Las Vegas) was a focused opportunity to engage deeply with partners, validate strategic priorities, and assess how emerging trends are influencing the future of healthcare professional (HCP) marketing.

Representing Doceree at the event were Julius Ramirez, EVP & GM, D ata & Partnerships, and Dan Baroff, Strategic Partnership Manager. Over 2.5 days, the team held more than 20 high-value meetings with existing, new, and prospective partners—conversations centered not on introductions, but on meaningful collaboration, alignment, and growth within pharma and life sciences marketing.

Engaging Partners Across the Programmatic and Data Ecosystem

Doceree met with a broad set of partners spanning supply, data, identity, measurement, and AI-driven technology. These included UseIntegral, Media.Net, TiVO, Access Plural, DoubleVerify, Definitive Healthcare, Bombora, IAS, AT Data, Zmaticoo, TheBrave.IO, Datavant, SemantIQ, Semcasting, Index Exchange, Dappier, Swym.AI, Yahoo SSP, Zeta Global, OpenX, and LG Ad Solutions.

Across these discussions, partners consistently expressed strong interest in healthcare and pharma marketing, while acknowledging the challenges of breaking into the space. Many view Doceree as a differentiated entry point—one that brings both credibility and purpose-built capabilities to HCP engagement.

Clear Validation of Doceree’s Differentiation

One of the strongest themes at CES was validation of Doceree’s position as the only independent HCP marketing platform. Partners repeatedly highlighted:

• Doceree’s commitment to remaining exclusively focused on healthcare professionals
• Platform and technical capabilities that address challenges generalist platforms struggle to solve
• Interest in partnering more deeply as they look to expand into pharma, where access, compliance, and precision remain barriers

This feedback reinforced that Doceree’s HCP-first strategy continues to resonate strongly across the ecosystem.

Privacy and Compliance as the Foundation for Growth

Privacy and compliance were central to nearly every conversation. As the industry looks toward more sophisticated use of healthcare-related signals, partners emphasized:

• The importance of real-world data (RWD), expert determinations, and tokenization when thinking about future use of PHI, PII, and patient data
• The need for ongoing investment in compliance certifications and regulatory update services as a baseline requirement
• Tokenization as a market standard—both to ensure compliance and to preserve identity while maintaining trust

These discussions reinforced the importance of building innovation on a strong compliance foundation.

Looking Ahead

Doceree’s CES 2026 engagement reinforced its leadership in HCP marketing at a time when precision, privacy, and performance matter more than ever. Strong partner validation, clear ecosystem trends, and forward-looking conversations confirmed that Doceree is well positioned to continue shaping how healthcare audiences are reached—responsibly, effectively, and at scale.